Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 2 Breast Neoplasms 2 Acquired Immunodeficiency Syndrome 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Ovarian Cysts 1 Neoplasms 1 Menorrhagia 1 Leiomyoma 1 High-grade Anal Intraepithelial Neoplasia 1 HIV Infections 1 Endometriosis 1 Benign Ovarian Tumor 1 Anus Neoplasms 1

Interventions

Colposcopy 9 Imiquimod 7 Conization 7 Papillomavirus Vaccines 6 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6 Cryotherapy 6 human papillomavirus vaccine, L1 type 16, 18 4 Blood Specimen Collection 4 Vaginal Smears 3 Vaccines 3 Papanicolaou Test 3 VGX-3100 2 Topotecan 2 Proflavine 2 Polymerase Chain Reaction 2 Paclitaxel 2 Mass Screening 2 Human Papillomavirus DNA Tests 2 Fluorouracil 2 Cisplatin 2 Biopsy 2 Acetic Acid 2 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2 terameprocol 1 poly(gamma-glutamic acid) 1 methyl 5-aminolevulinate 1 lime 1 human papillomavirus vaccine, TA 1 hecolin 1 fludarabine phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Uterine Cervical Dysplasia × Electrocoagulation × Clear all

NCT02956239 2024-07-08

DELTA

International Agency for Research on Cancer

Phase NA Completed

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡